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Background/Introduction
Implantation of transcatheter aortic bioprosthesis has
become a procedure with increasingly relevance in medical
practice for the treatment of aortic stenosis, especially in
patients with high or prohibitive surgical risk for tradi-
tional surgery. The presence of mitral regurgitation (MR)
may be associated with increased morbidity and mortality,
however, some studies have shown reduction in the degree
of regurgitation of this valve after treatment of the aortic
valve.
Aims/Objectives
To evaluate MR evolution in three patients with moderate
to severe MR, and who underwent transcatheter implanta-
tion of aortic bioprosthesis trough transapical approach
due to severe aortic stenosis.
Method
Data were collected from medical records and databases.
Of the 22 patients undergoing transcatheter implantation
of aortic bioprosthesis trough transapical approach, due to
severe aortic stenosis, in our service from May 2012 to
May 2015, four were presenting with MR of moderate to
severe before surgery. In one of these cases, we had no
access to the postoperative echocardiogram. Regarding the
group of three patients, two were females, mean age was
80.33 ± 7.63 years, Euroscore II average of 11.25 ± 3.1,
STS-average score of 15.06 ± 9 26.
Results
None of the three patients had complications in the proce-
dure or during the immediate postoperative period,
finding themselves alive, and in ambulatorial follow-up,
with an average follow-up time of 19.33 ± 14.84 months.
Echocardiography before hospital discharge, and outpati-
ent follow-up showed aortic valve prostheses normal func-
tioning, medium transprosthetic gradient less than
10 mmHg, and mild mitral insufficiency. Only one patient
(33%) showed discreet paravalvular reflux.
Discussion/Conclusion
In this study, patients undergoing transcatheter implanta-
tion of aortic bioprosthesis trough transapical approach,
due to severe aortic stenosis, which had preoperative mod-
erate or severe MR, demonstrated good outcome in the
postoperative period and in ambulatorial follow-up, as
well as significant reduction in mitral valve regurgitation.
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